The UBS Asset Management (UBS-AM) Infrastructure Debt Platform has financed CapMan Infra’s acquisition of Koiviston Auto, a Finnish transport operator with the largest bus fleet in the country. The financing will also fund Koiviston Auto’s expansion into electric vehicles, with aims to increase the number of electric buses in its

Private equity firm Willis & Smith Capital and its affiliates have acquired R&B Grinding (R&B), a manufacturer of machined components to a variety of industrial customers, including Fortune 500 original equipment manufacturers. Since its founding in 1958 by the Biddle Family, R&B remains a community pillar employing over 100 team

Main Capital Partners (Main) has backed biomedion, a leading GxP data cloud platform provider. biomedion offers an extensive suite of software that is deployed across all “good practice” areas (GxP) in the life and health sciences industry, where quality guidelines and regulations are of paramount importance. biomedion is headquartered in

Ironwood Capital, a provider of non-control growth capital to middle market companies across the US has exited The Facilities Group (TFG), a national facilities maintenance business formed by Revolent Capital Solutions, and a portfolio company of the firm. The Facilities Group is a provider of integrated facilities maintenance solutions. The

Industrial Opportunity Partners (IOP), an operations-focused private equity firm, has completed the sale of portfolio company Midwest Paper Group Holdings, Inc (Midwest Paper) to McKinley Paper Company, a subsidiary of Bio Pappel SA de CV (Bio Pappel), a manufacturer of paper and packaging products in North and Latin America. IOP

Private investment firm Inverness Graham’s Governance, Risk and Compliance (GRC) solutions company, Syntrio, has acquired ClearView Strategic Partners (ClearView), a provider of ethics reporting & management systems and whistleblower technology solutions. The transaction marks the fifth add-on acquisition completed during Inverness Graham’s ownership, and will provide Syntrio with access to

Vensica Therapeutics (Vensica), a clinical stage biopharmaceutical company, has closed a USD19 million investment round. Vensica executed a strategic collaboration agreement with Merz Therapeutics in 2021 and the Merz Group is participating in Vensica’s financing with up to USD3 million, bringing the total round to up to USD19 million. The

Reliance Health, an emerging markets-focused digital healthcare provider, has secured USD40 million in a Series B funding round led by General Atlantic. Partech, Picus Capital, Tencent Exploration, AAIC (Asia Africa Investment and Consulting), P1 Ventures, Laerdal Million Lives Fund, M3, Inc, and Arvantis Social Foundation also participated. With this funding,